Skip to main content
Caplight Logo









MoleSense

MoleSense

Private
EpalingesHealthcare & Life Scienceshttps://www.molesense.ch/

Last Round

Grant

Jun 25, 2026

Total Funding Raised

$620,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

MoleSense is a medical technology company that develops molecular wearables for continuous, non-invasive monitoring of biochemical markers in maternal healthcare.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Precision Medicine, Sensors, Medical AI

Business Model

B2B

Customer Profile

Hardware + Subscription, Subscription SaaS

AI Layer

Application

Keywords

wearable medical deviceremote patient monitoringRPMhigh-risk pregnancyfemtechbiochemical sensormaternal healthcontinuous monitoringdigital healthclinical decision supportsweat sensingprecision medicinehealth IoTmedical AIpredictive analytics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MoleSense Comparables

Compare MoleSense with similar companies based on industry and business-model similarity.

MoleSense comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Impli
78%
PreTeL, Inc.
76%
Bloomlife
70%

MoleSense Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 25, 2026
DebtMar 23, 2026
SeedOct 28, 2025
GrantOct 22, 2025

Key People

Founding team and executive leadership

Gian Luca Barbruni

Chief Executive Officer & Founder

Founding Team

MoleSense Investors

Notable investors and investment history

MoleSense investors
InvestorRounds
Gebert Rüf StiftungGrant
Venture KickSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 25, 2026

    $110K grant received from Biopôle SA.

  • Apr 6, 2026

    Grew 100% QoQ, from 5 to 10 employees.

MoleSense Filings

Explore SEC and related filing metadata, where available.

MoleSense filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MoleSense's valuation, stock price, and market status.

Is MoleSense a public or private company?

MoleSense is a private company.

What is the current stock price of MoleSense?

MoleSense is a private company with no public stock price. No recent secondary market data is available.

How much is MoleSense worth (valuation)?

Valuation information for MoleSense is not publicly available.

Can I buy MoleSense stock?

MoleSense shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MoleSense's last funding round?

MoleSense's most recent funding round was Grant on June 25, 2026.

Who are the main investors in MoleSense?

Key investors in MoleSense include Gebert Rüf Stiftung, Venture Kick.

Will MoleSense IPO soon?

No public IPO plans have been announced for MoleSense.

How can I track MoleSense secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MoleSense's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEpalinges
Employee Range10
Year Founded2025
Last FundingJun 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?